nodes	percent_of_prediction	percent_of_DWPC	metapath
Fosphenytoin—ALB—multiple sclerosis	0.383	1	CbGaD
Fosphenytoin—ALB—Prednisone—multiple sclerosis	0.0549	0.137	CbGbCtD
Fosphenytoin—CYP3A4—Fingolimod—multiple sclerosis	0.0441	0.11	CbGbCtD
Fosphenytoin—CYP2C19—Prednisone—multiple sclerosis	0.0356	0.0891	CbGbCtD
Fosphenytoin—CYP2B6—Dexamethasone—multiple sclerosis	0.035	0.0875	CbGbCtD
Fosphenytoin—CYP3A4—Methylprednisolone—multiple sclerosis	0.0284	0.0711	CbGbCtD
Fosphenytoin—ALB—Methotrexate—multiple sclerosis	0.0275	0.0689	CbGbCtD
Fosphenytoin—CYP2C8—Dexamethasone—multiple sclerosis	0.0265	0.0663	CbGbCtD
Fosphenytoin—CYP2C19—Dexamethasone—multiple sclerosis	0.0222	0.0556	CbGbCtD
Fosphenytoin—CYP3A4—Triamcinolone—multiple sclerosis	0.0215	0.0539	CbGbCtD
Fosphenytoin—CYP3A4—Mitoxantrone—multiple sclerosis	0.0207	0.0519	CbGbCtD
Fosphenytoin—CYP2C9—Dexamethasone—multiple sclerosis	0.0185	0.0462	CbGbCtD
Fosphenytoin—CYP3A4—Betamethasone—multiple sclerosis	0.0185	0.0462	CbGbCtD
Fosphenytoin—CYP3A4—Prednisolone—multiple sclerosis	0.0182	0.0456	CbGbCtD
Fosphenytoin—CYP3A4—Prednisone—multiple sclerosis	0.0172	0.0431	CbGbCtD
Fosphenytoin—CYP3A4—Dexamethasone—multiple sclerosis	0.0107	0.0269	CbGbCtD
Fosphenytoin—SCN5A—L1CAM interactions—CD24—multiple sclerosis	0.000646	0.0428	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000515	0.0341	CbGpPWpGaD
Fosphenytoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000381	0.0253	CbGpPWpGaD
Fosphenytoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000381	0.0253	CbGpPWpGaD
Fosphenytoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000263	0.0174	CbGpPWpGaD
Fosphenytoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000263	0.0174	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—CD24—multiple sclerosis	0.000244	0.0162	CbGpPWpGaD
Fosphenytoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000242	0.016	CbGpPWpGaD
Fosphenytoin—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000242	0.016	CbGpPWpGaD
Fosphenytoin—CYP2B6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000239	0.0158	CbGpPWpGaD
Fosphenytoin—CYP2B6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000239	0.0158	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—C4A—multiple sclerosis	0.000214	0.0142	CbGpPWpGaD
Fosphenytoin—Hypertension—Prednisolone—multiple sclerosis	0.000209	0.00104	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000207	0.00102	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000206	0.00102	CcSEcCtD
Fosphenytoin—Constipation—Mitoxantrone—multiple sclerosis	0.000206	0.00102	CcSEcCtD
Fosphenytoin—Bradycardia—Prednisone—multiple sclerosis	0.000206	0.00102	CcSEcCtD
Fosphenytoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000205	0.0136	CbGpPWpGaD
Fosphenytoin—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000205	0.0136	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Azathioprine—multiple sclerosis	0.000204	0.00101	CcSEcCtD
Fosphenytoin—Discomfort—Prednisolone—multiple sclerosis	0.000204	0.00101	CcSEcCtD
Fosphenytoin—CYP2C8—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000202	0.0134	CbGpPWpGaD
Fosphenytoin—CYP2C8—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000202	0.0134	CbGpPWpGaD
Fosphenytoin—Malaise—Triamcinolone—multiple sclerosis	0.000201	0.000996	CcSEcCtD
Fosphenytoin—Malaise—Methylprednisolone—multiple sclerosis	0.000201	0.000994	CcSEcCtD
Fosphenytoin—Vertigo—Triamcinolone—multiple sclerosis	0.0002	0.000992	CcSEcCtD
Fosphenytoin—Syncope—Triamcinolone—multiple sclerosis	0.0002	0.00099	CcSEcCtD
Fosphenytoin—Vertigo—Methylprednisolone—multiple sclerosis	0.0002	0.00099	CcSEcCtD
Fosphenytoin—Syncope—Methylprednisolone—multiple sclerosis	0.000199	0.000988	CcSEcCtD
Fosphenytoin—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000199	0.000984	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000198	0.00098	CcSEcCtD
Fosphenytoin—Dysuria—Methotrexate—multiple sclerosis	0.000198	0.000979	CcSEcCtD
Fosphenytoin—Dizziness—Azathioprine—multiple sclerosis	0.000197	0.000977	CcSEcCtD
Fosphenytoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000196	0.013	CbGpPWpGaD
Fosphenytoin—CYP2B6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000196	0.013	CbGpPWpGaD
Fosphenytoin—Loss of consciousness—Triamcinolone—multiple sclerosis	0.000196	0.000971	CcSEcCtD
Fosphenytoin—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.000196	0.000969	CcSEcCtD
Fosphenytoin—Shock—Prednisolone—multiple sclerosis	0.000195	0.000964	CcSEcCtD
Fosphenytoin—Cough—Triamcinolone—multiple sclerosis	0.000195	0.000964	CcSEcCtD
Fosphenytoin—Convulsion—Triamcinolone—multiple sclerosis	0.000193	0.000957	CcSEcCtD
Fosphenytoin—Tachycardia—Prednisolone—multiple sclerosis	0.000193	0.000957	CcSEcCtD
Fosphenytoin—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000193	0.000955	CcSEcCtD
Fosphenytoin—Convulsion—Methylprednisolone—multiple sclerosis	0.000193	0.000955	CcSEcCtD
Fosphenytoin—Hypertension—Triamcinolone—multiple sclerosis	0.000192	0.000953	CcSEcCtD
Fosphenytoin—Hypertension—Methylprednisolone—multiple sclerosis	0.000192	0.000951	CcSEcCtD
Fosphenytoin—Urticaria—Mitoxantrone—multiple sclerosis	0.000192	0.000949	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000191	0.000948	CcSEcCtD
Fosphenytoin—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000191	0.000944	CcSEcCtD
Fosphenytoin—Myalgia—Triamcinolone—multiple sclerosis	0.00019	0.00094	CcSEcCtD
Fosphenytoin—Vomiting—Azathioprine—multiple sclerosis	0.00019	0.00094	CcSEcCtD
Fosphenytoin—Pneumonia—Methotrexate—multiple sclerosis	0.00019	0.000939	CcSEcCtD
Fosphenytoin—Arthralgia—Methylprednisolone—multiple sclerosis	0.000189	0.000938	CcSEcCtD
Fosphenytoin—Myalgia—Methylprednisolone—multiple sclerosis	0.000189	0.000938	CcSEcCtD
Fosphenytoin—Rash—Azathioprine—multiple sclerosis	0.000188	0.000932	CcSEcCtD
Fosphenytoin—Dermatitis—Azathioprine—multiple sclerosis	0.000188	0.000931	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000188	0.00093	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000188	0.00093	CcSEcCtD
Fosphenytoin—Discomfort—Triamcinolone—multiple sclerosis	0.000188	0.000929	CcSEcCtD
Fosphenytoin—Discomfort—Methylprednisolone—multiple sclerosis	0.000187	0.000927	CcSEcCtD
Fosphenytoin—Headache—Azathioprine—multiple sclerosis	0.000187	0.000926	CcSEcCtD
Fosphenytoin—Dry mouth—Triamcinolone—multiple sclerosis	0.000186	0.00092	CcSEcCtD
Fosphenytoin—Renal failure—Methotrexate—multiple sclerosis	0.000185	0.000917	CcSEcCtD
Fosphenytoin—Conjunctivitis—Methotrexate—multiple sclerosis	0.000183	0.000907	CcSEcCtD
Fosphenytoin—Confusional state—Methylprednisolone—multiple sclerosis	0.000183	0.000907	CcSEcCtD
Fosphenytoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000183	0.0121	CbGpPWpGaD
Fosphenytoin—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000183	0.0121	CbGpPWpGaD
Fosphenytoin—Malaise—Dexamethasone—multiple sclerosis	0.000182	0.000904	CcSEcCtD
Fosphenytoin—Malaise—Betamethasone—multiple sclerosis	0.000182	0.000904	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000182	0.000901	CcSEcCtD
Fosphenytoin—Vertigo—Betamethasone—multiple sclerosis	0.000182	0.0009	CcSEcCtD
Fosphenytoin—Vertigo—Dexamethasone—multiple sclerosis	0.000182	0.0009	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000182	0.000899	CcSEcCtD
Fosphenytoin—Syncope—Betamethasone—multiple sclerosis	0.000181	0.000899	CcSEcCtD
Fosphenytoin—Syncope—Dexamethasone—multiple sclerosis	0.000181	0.000899	CcSEcCtD
Fosphenytoin—Infection—Triamcinolone—multiple sclerosis	0.000181	0.000895	CcSEcCtD
Fosphenytoin—Sweating—Methotrexate—multiple sclerosis	0.000181	0.000895	CcSEcCtD
Fosphenytoin—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00018	0.012	CbGpPWpGaD
Fosphenytoin—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00018	0.012	CbGpPWpGaD
Fosphenytoin—Infection—Methylprednisolone—multiple sclerosis	0.00018	0.000893	CcSEcCtD
Fosphenytoin—Shock—Triamcinolone—multiple sclerosis	0.000179	0.000887	CcSEcCtD
Fosphenytoin—Insomnia—Prednisolone—multiple sclerosis	0.000179	0.000886	CcSEcCtD
Fosphenytoin—Shock—Methylprednisolone—multiple sclerosis	0.000179	0.000885	CcSEcCtD
Fosphenytoin—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000178	0.000881	CcSEcCtD
Fosphenytoin—Loss of consciousness—Betamethasone—multiple sclerosis	0.000178	0.000881	CcSEcCtD
Fosphenytoin—Epistaxis—Methotrexate—multiple sclerosis	0.000178	0.00088	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisolone—multiple sclerosis	0.000178	0.00088	CcSEcCtD
Fosphenytoin—Tachycardia—Triamcinolone—multiple sclerosis	0.000178	0.00088	CcSEcCtD
Fosphenytoin—Nausea—Azathioprine—multiple sclerosis	0.000177	0.000878	CcSEcCtD
Fosphenytoin—Tachycardia—Methylprednisolone—multiple sclerosis	0.000177	0.000878	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000176	0.000871	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000176	0.000869	CcSEcCtD
Fosphenytoin—Convulsion—Betamethasone—multiple sclerosis	0.000175	0.000868	CcSEcCtD
Fosphenytoin—Convulsion—Dexamethasone—multiple sclerosis	0.000175	0.000868	CcSEcCtD
Fosphenytoin—Hypertension—Dexamethasone—multiple sclerosis	0.000175	0.000865	CcSEcCtD
Fosphenytoin—Hypertension—Betamethasone—multiple sclerosis	0.000175	0.000865	CcSEcCtD
Fosphenytoin—SCN5A—Developmental Biology—CD24—multiple sclerosis	0.000174	0.0115	CbGpPWpGaD
Fosphenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000173	0.0115	CbGpPWpGaD
Fosphenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000173	0.0115	CbGpPWpGaD
Fosphenytoin—Asthenia—Mitoxantrone—multiple sclerosis	0.000173	0.000857	CcSEcCtD
Fosphenytoin—Myalgia—Dexamethasone—multiple sclerosis	0.000172	0.000853	CcSEcCtD
Fosphenytoin—Myalgia—Betamethasone—multiple sclerosis	0.000172	0.000853	CcSEcCtD
Fosphenytoin—Discomfort—Dexamethasone—multiple sclerosis	0.00017	0.000843	CcSEcCtD
Fosphenytoin—Discomfort—Betamethasone—multiple sclerosis	0.00017	0.000843	CcSEcCtD
Fosphenytoin—Hypotension—Methylprednisolone—multiple sclerosis	0.00017	0.00084	CcSEcCtD
Fosphenytoin—Pharyngitis—Methotrexate—multiple sclerosis	0.000168	0.000832	CcSEcCtD
Fosphenytoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000167	0.011	CbGpPWpGaD
Fosphenytoin—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000167	0.011	CbGpPWpGaD
Fosphenytoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000166	0.011	CbGpPWpGaD
Fosphenytoin—CYP2C8—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000166	0.011	CbGpPWpGaD
Fosphenytoin—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000166	0.000821	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000165	0.000819	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000165	0.000818	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000165	0.000818	CcSEcCtD
Fosphenytoin—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000165	0.000817	CcSEcCtD
Fosphenytoin—Insomnia—Triamcinolone—multiple sclerosis	0.000165	0.000815	CcSEcCtD
Fosphenytoin—CYP2C9—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000165	0.0109	CbGpPWpGaD
Fosphenytoin—CYP2C9—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000165	0.0109	CbGpPWpGaD
Fosphenytoin—Insomnia—Methylprednisolone—multiple sclerosis	0.000164	0.000813	CcSEcCtD
Fosphenytoin—Infection—Betamethasone—multiple sclerosis	0.000164	0.000812	CcSEcCtD
Fosphenytoin—Infection—Dexamethasone—multiple sclerosis	0.000164	0.000812	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Prednisone—multiple sclerosis	0.000163	0.00081	CcSEcCtD
Fosphenytoin—Paraesthesia—Triamcinolone—multiple sclerosis	0.000163	0.000809	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisolone—multiple sclerosis	0.000163	0.000808	CcSEcCtD
Fosphenytoin—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000163	0.000808	CcSEcCtD
Fosphenytoin—Anaemia—Prednisone—multiple sclerosis	0.000163	0.000807	CcSEcCtD
Fosphenytoin—Shock—Dexamethasone—multiple sclerosis	0.000162	0.000805	CcSEcCtD
Fosphenytoin—Shock—Betamethasone—multiple sclerosis	0.000162	0.000805	CcSEcCtD
Fosphenytoin—Dyspnoea—Triamcinolone—multiple sclerosis	0.000162	0.000804	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	0.000162	0.0107	CbGpPWpGaD
Fosphenytoin—Agitation—Prednisone—multiple sclerosis	0.000162	0.000802	CcSEcCtD
Fosphenytoin—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	0.000162	0.0107	CbGpPWpGaD
Fosphenytoin—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000162	0.000801	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000162	0.000801	CcSEcCtD
Fosphenytoin—Tachycardia—Betamethasone—multiple sclerosis	0.000161	0.000798	CcSEcCtD
Fosphenytoin—Tachycardia—Dexamethasone—multiple sclerosis	0.000161	0.000798	CcSEcCtD
Fosphenytoin—Dyspepsia—Triamcinolone—multiple sclerosis	0.00016	0.000793	CcSEcCtD
Fosphenytoin—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00016	0.000792	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00016	0.000791	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00016	0.000791	CcSEcCtD
Fosphenytoin—Malaise—Prednisone—multiple sclerosis	0.000159	0.000787	CcSEcCtD
Fosphenytoin—Vertigo—Prednisone—multiple sclerosis	0.000158	0.000784	CcSEcCtD
Fosphenytoin—Syncope—Prednisone—multiple sclerosis	0.000158	0.000783	CcSEcCtD
Fosphenytoin—Tinnitus—Methotrexate—multiple sclerosis	0.000158	0.000781	CcSEcCtD
Fosphenytoin—Anorexia—Dexamethasone—multiple sclerosis	0.000157	0.00078	CcSEcCtD
Fosphenytoin—Anorexia—Betamethasone—multiple sclerosis	0.000157	0.00078	CcSEcCtD
Fosphenytoin—Urticaria—Prednisolone—multiple sclerosis	0.000157	0.000779	CcSEcCtD
Fosphenytoin—Loss of consciousness—Prednisone—multiple sclerosis	0.000155	0.000767	CcSEcCtD
Fosphenytoin—Hypotension—Dexamethasone—multiple sclerosis	0.000154	0.000764	CcSEcCtD
Fosphenytoin—Hypotension—Betamethasone—multiple sclerosis	0.000154	0.000764	CcSEcCtD
Fosphenytoin—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000153	0.0102	CbGpPWpGaD
Fosphenytoin—Vomiting—Mitoxantrone—multiple sclerosis	0.000153	0.00076	CcSEcCtD
Fosphenytoin—Convulsion—Prednisone—multiple sclerosis	0.000153	0.000756	CcSEcCtD
Fosphenytoin—Hypertension—Prednisone—multiple sclerosis	0.000152	0.000753	CcSEcCtD
Fosphenytoin—Rash—Mitoxantrone—multiple sclerosis	0.000152	0.000753	CcSEcCtD
Fosphenytoin—Dermatitis—Mitoxantrone—multiple sclerosis	0.000152	0.000753	CcSEcCtD
Fosphenytoin—Chills—Methotrexate—multiple sclerosis	0.000152	0.000752	CcSEcCtD
Fosphenytoin—Headache—Mitoxantrone—multiple sclerosis	0.000151	0.000748	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00015	0.000745	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00015	0.000745	CcSEcCtD
Fosphenytoin—Arthralgia—Prednisone—multiple sclerosis	0.00015	0.000743	CcSEcCtD
Fosphenytoin—Myalgia—Prednisone—multiple sclerosis	0.00015	0.000743	CcSEcCtD
Fosphenytoin—Feeling abnormal—Triamcinolone—multiple sclerosis	0.00015	0.000743	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.00015	0.000741	CcSEcCtD
Fosphenytoin—Insomnia—Dexamethasone—multiple sclerosis	0.000149	0.00074	CcSEcCtD
Fosphenytoin—Insomnia—Betamethasone—multiple sclerosis	0.000149	0.00074	CcSEcCtD
Fosphenytoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000148	0.00982	CbGpPWpGaD
Fosphenytoin—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000148	0.00982	CbGpPWpGaD
Fosphenytoin—Paraesthesia—Betamethasone—multiple sclerosis	0.000148	0.000734	CcSEcCtD
Fosphenytoin—Paraesthesia—Dexamethasone—multiple sclerosis	0.000148	0.000734	CcSEcCtD
Fosphenytoin—Discomfort—Prednisone—multiple sclerosis	0.000148	0.000734	CcSEcCtD
Fosphenytoin—Dyspepsia—Betamethasone—multiple sclerosis	0.000145	0.00072	CcSEcCtD
Fosphenytoin—Dyspepsia—Dexamethasone—multiple sclerosis	0.000145	0.00072	CcSEcCtD
Fosphenytoin—Urticaria—Triamcinolone—multiple sclerosis	0.000145	0.000716	CcSEcCtD
Fosphenytoin—Urticaria—Methylprednisolone—multiple sclerosis	0.000144	0.000714	CcSEcCtD
Fosphenytoin—Dysgeusia—Methotrexate—multiple sclerosis	0.000144	0.000714	CcSEcCtD
Fosphenytoin—Body temperature increased—Triamcinolone—multiple sclerosis	0.000144	0.000713	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Prednisone—multiple sclerosis	0.000144	0.000712	CcSEcCtD
Fosphenytoin—Decreased appetite—Dexamethasone—multiple sclerosis	0.000144	0.000711	CcSEcCtD
Fosphenytoin—Decreased appetite—Betamethasone—multiple sclerosis	0.000144	0.000711	CcSEcCtD
Fosphenytoin—Nausea—Mitoxantrone—multiple sclerosis	0.000143	0.00071	CcSEcCtD
Fosphenytoin—Infection—Prednisone—multiple sclerosis	0.000143	0.000708	CcSEcCtD
Fosphenytoin—Back pain—Methotrexate—multiple sclerosis	0.000142	0.000705	CcSEcCtD
Fosphenytoin—Shock—Prednisone—multiple sclerosis	0.000141	0.000701	CcSEcCtD
Fosphenytoin—Tachycardia—Prednisone—multiple sclerosis	0.00014	0.000695	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Prednisone—multiple sclerosis	0.000139	0.000689	CcSEcCtD
Fosphenytoin—Anorexia—Prednisone—multiple sclerosis	0.000137	0.000679	CcSEcCtD
Fosphenytoin—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000137	0.000677	CcSEcCtD
Fosphenytoin—Anaemia—Methotrexate—multiple sclerosis	0.000136	0.000674	CcSEcCtD
Fosphenytoin—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000136	0.000674	CcSEcCtD
Fosphenytoin—Feeling abnormal—Betamethasone—multiple sclerosis	0.000136	0.000674	CcSEcCtD
Fosphenytoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000135	0.00896	CbGpPWpGaD
Fosphenytoin—CYP2C9—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000135	0.00896	CbGpPWpGaD
Fosphenytoin—Malaise—Methotrexate—multiple sclerosis	0.000133	0.000658	CcSEcCtD
Fosphenytoin—Vertigo—Methotrexate—multiple sclerosis	0.000132	0.000655	CcSEcCtD
Fosphenytoin—ALB—Platelet degranulation—PLEK—multiple sclerosis	0.000132	0.00874	CbGpPWpGaD
Fosphenytoin—Leukopenia—Methotrexate—multiple sclerosis	0.000132	0.000653	CcSEcCtD
Fosphenytoin—Urticaria—Betamethasone—multiple sclerosis	0.000131	0.00065	CcSEcCtD
Fosphenytoin—Urticaria—Dexamethasone—multiple sclerosis	0.000131	0.00065	CcSEcCtD
Fosphenytoin—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000131	0.000649	CcSEcCtD
Fosphenytoin—Dizziness—Prednisolone—multiple sclerosis	0.000131	0.000648	CcSEcCtD
Fosphenytoin—Asthenia—Triamcinolone—multiple sclerosis	0.000131	0.000647	CcSEcCtD
Fosphenytoin—Body temperature increased—Dexamethasone—multiple sclerosis	0.000131	0.000647	CcSEcCtD
Fosphenytoin—Body temperature increased—Betamethasone—multiple sclerosis	0.000131	0.000647	CcSEcCtD
Fosphenytoin—Asthenia—Methylprednisolone—multiple sclerosis	0.00013	0.000645	CcSEcCtD
Fosphenytoin—Insomnia—Prednisone—multiple sclerosis	0.00013	0.000644	CcSEcCtD
Fosphenytoin—Paraesthesia—Prednisone—multiple sclerosis	0.000129	0.00064	CcSEcCtD
Fosphenytoin—Pruritus—Triamcinolone—multiple sclerosis	0.000129	0.000638	CcSEcCtD
Fosphenytoin—Cough—Methotrexate—multiple sclerosis	0.000128	0.000636	CcSEcCtD
Fosphenytoin—Pruritus—Methylprednisolone—multiple sclerosis	0.000128	0.000636	CcSEcCtD
Fosphenytoin—Convulsion—Methotrexate—multiple sclerosis	0.000128	0.000632	CcSEcCtD
Fosphenytoin—Dyspepsia—Prednisone—multiple sclerosis	0.000127	0.000627	CcSEcCtD
Fosphenytoin—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000126	0.00833	CbGpPWpGaD
Fosphenytoin—Arthralgia—Methotrexate—multiple sclerosis	0.000125	0.000621	CcSEcCtD
Fosphenytoin—Myalgia—Methotrexate—multiple sclerosis	0.000125	0.000621	CcSEcCtD
Fosphenytoin—Decreased appetite—Prednisone—multiple sclerosis	0.000125	0.000619	CcSEcCtD
Fosphenytoin—Rash—Prednisolone—multiple sclerosis	0.000125	0.000618	CcSEcCtD
Fosphenytoin—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000125	0.00826	CbGpPWpGaD
Fosphenytoin—Dermatitis—Prednisolone—multiple sclerosis	0.000125	0.000617	CcSEcCtD
Fosphenytoin—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000124	0.000615	CcSEcCtD
Fosphenytoin—Headache—Prednisolone—multiple sclerosis	0.000124	0.000614	CcSEcCtD
Fosphenytoin—Discomfort—Methotrexate—multiple sclerosis	0.000124	0.000613	CcSEcCtD
Fosphenytoin—Constipation—Prednisone—multiple sclerosis	0.000123	0.000609	CcSEcCtD
Fosphenytoin—Confusional state—Methotrexate—multiple sclerosis	0.000121	0.0006	CcSEcCtD
Fosphenytoin—Dizziness—Triamcinolone—multiple sclerosis	0.00012	0.000596	CcSEcCtD
Fosphenytoin—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00012	0.000595	CcSEcCtD
Fosphenytoin—Dizziness—Methylprednisolone—multiple sclerosis	0.00012	0.000595	CcSEcCtD
Fosphenytoin—Infection—Methotrexate—multiple sclerosis	0.000119	0.000591	CcSEcCtD
Fosphenytoin—Feeling abnormal—Prednisone—multiple sclerosis	0.000118	0.000587	CcSEcCtD
Fosphenytoin—Asthenia—Dexamethasone—multiple sclerosis	0.000118	0.000587	CcSEcCtD
Fosphenytoin—Asthenia—Betamethasone—multiple sclerosis	0.000118	0.000587	CcSEcCtD
Fosphenytoin—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000118	0.000583	CcSEcCtD
Fosphenytoin—Nausea—Prednisolone—multiple sclerosis	0.000118	0.000582	CcSEcCtD
Fosphenytoin—Pruritus—Dexamethasone—multiple sclerosis	0.000117	0.000579	CcSEcCtD
Fosphenytoin—Pruritus—Betamethasone—multiple sclerosis	0.000117	0.000579	CcSEcCtD
Fosphenytoin—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000116	0.000575	CcSEcCtD
Fosphenytoin—Vomiting—Triamcinolone—multiple sclerosis	0.000116	0.000573	CcSEcCtD
Fosphenytoin—Vomiting—Methylprednisolone—multiple sclerosis	0.000115	0.000572	CcSEcCtD
Fosphenytoin—Rash—Triamcinolone—multiple sclerosis	0.000115	0.000568	CcSEcCtD
Fosphenytoin—Dermatitis—Triamcinolone—multiple sclerosis	0.000115	0.000568	CcSEcCtD
Fosphenytoin—Anorexia—Methotrexate—multiple sclerosis	0.000115	0.000567	CcSEcCtD
Fosphenytoin—Rash—Methylprednisolone—multiple sclerosis	0.000114	0.000567	CcSEcCtD
Fosphenytoin—Dermatitis—Methylprednisolone—multiple sclerosis	0.000114	0.000567	CcSEcCtD
Fosphenytoin—Urticaria—Prednisone—multiple sclerosis	0.000114	0.000566	CcSEcCtD
Fosphenytoin—Headache—Triamcinolone—multiple sclerosis	0.000114	0.000565	CcSEcCtD
Fosphenytoin—Headache—Methylprednisolone—multiple sclerosis	0.000114	0.000563	CcSEcCtD
Fosphenytoin—Body temperature increased—Prednisone—multiple sclerosis	0.000114	0.000563	CcSEcCtD
Fosphenytoin—Diarrhoea—Dexamethasone—multiple sclerosis	0.000113	0.00056	CcSEcCtD
Fosphenytoin—Diarrhoea—Betamethasone—multiple sclerosis	0.000113	0.00056	CcSEcCtD
Fosphenytoin—Hypotension—Methotrexate—multiple sclerosis	0.000112	0.000556	CcSEcCtD
Fosphenytoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.00011	0.00729	CbGpPWpGaD
Fosphenytoin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.00011	0.00729	CbGpPWpGaD
Fosphenytoin—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000109	0.000542	CcSEcCtD
Fosphenytoin—Dizziness—Betamethasone—multiple sclerosis	0.000109	0.000541	CcSEcCtD
Fosphenytoin—Dizziness—Dexamethasone—multiple sclerosis	0.000109	0.000541	CcSEcCtD
Fosphenytoin—Insomnia—Methotrexate—multiple sclerosis	0.000109	0.000538	CcSEcCtD
Fosphenytoin—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000109	0.00719	CbGpPWpGaD
Fosphenytoin—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000109	0.00719	CbGpPWpGaD
Fosphenytoin—Nausea—Triamcinolone—multiple sclerosis	0.000108	0.000535	CcSEcCtD
Fosphenytoin—Paraesthesia—Methotrexate—multiple sclerosis	0.000108	0.000534	CcSEcCtD
Fosphenytoin—Nausea—Methylprednisolone—multiple sclerosis	0.000108	0.000534	CcSEcCtD
Fosphenytoin—Dyspnoea—Methotrexate—multiple sclerosis	0.000107	0.000531	CcSEcCtD
Fosphenytoin—Somnolence—Methotrexate—multiple sclerosis	0.000107	0.000529	CcSEcCtD
Fosphenytoin—Dyspepsia—Methotrexate—multiple sclerosis	0.000106	0.000524	CcSEcCtD
Fosphenytoin—Vomiting—Dexamethasone—multiple sclerosis	0.000105	0.00052	CcSEcCtD
Fosphenytoin—Vomiting—Betamethasone—multiple sclerosis	0.000105	0.00052	CcSEcCtD
Fosphenytoin—Decreased appetite—Methotrexate—multiple sclerosis	0.000104	0.000517	CcSEcCtD
Fosphenytoin—CYP2B6—Biological oxidations—CYP24A1—multiple sclerosis	0.000104	0.0069	CbGpPWpGaD
Fosphenytoin—CYP2B6—Biological oxidations—CYP27B1—multiple sclerosis	0.000104	0.0069	CbGpPWpGaD
Fosphenytoin—Rash—Dexamethasone—multiple sclerosis	0.000104	0.000516	CcSEcCtD
Fosphenytoin—Rash—Betamethasone—multiple sclerosis	0.000104	0.000516	CcSEcCtD
Fosphenytoin—Dermatitis—Betamethasone—multiple sclerosis	0.000104	0.000515	CcSEcCtD
Fosphenytoin—Dermatitis—Dexamethasone—multiple sclerosis	0.000104	0.000515	CcSEcCtD
Fosphenytoin—Headache—Dexamethasone—multiple sclerosis	0.000103	0.000512	CcSEcCtD
Fosphenytoin—Headache—Betamethasone—multiple sclerosis	0.000103	0.000512	CcSEcCtD
Fosphenytoin—Asthenia—Prednisone—multiple sclerosis	0.000103	0.000511	CcSEcCtD
Fosphenytoin—CYP2B6—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000103	0.00681	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000103	0.00681	CbGpPWpGaD
Fosphenytoin—Pruritus—Prednisone—multiple sclerosis	0.000102	0.000504	CcSEcCtD
Fosphenytoin—Feeling abnormal—Methotrexate—multiple sclerosis	9.9e-05	0.00049	CcSEcCtD
Fosphenytoin—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	9.87e-05	0.00654	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Prednisone—multiple sclerosis	9.84e-05	0.000487	CcSEcCtD
Fosphenytoin—Nausea—Dexamethasone—multiple sclerosis	9.81e-05	0.000486	CcSEcCtD
Fosphenytoin—Nausea—Betamethasone—multiple sclerosis	9.81e-05	0.000486	CcSEcCtD
Fosphenytoin—Urticaria—Methotrexate—multiple sclerosis	9.55e-05	0.000473	CcSEcCtD
Fosphenytoin—Dizziness—Prednisone—multiple sclerosis	9.51e-05	0.000471	CcSEcCtD
Fosphenytoin—Body temperature increased—Methotrexate—multiple sclerosis	9.5e-05	0.000471	CcSEcCtD
Fosphenytoin—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	9.29e-05	0.00615	CbGpPWpGaD
Fosphenytoin—Vomiting—Prednisone—multiple sclerosis	9.14e-05	0.000453	CcSEcCtD
Fosphenytoin—Rash—Prednisone—multiple sclerosis	9.07e-05	0.000449	CcSEcCtD
Fosphenytoin—Dermatitis—Prednisone—multiple sclerosis	9.06e-05	0.000449	CcSEcCtD
Fosphenytoin—Headache—Prednisone—multiple sclerosis	9.01e-05	0.000446	CcSEcCtD
Fosphenytoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	8.92e-05	0.00591	CbGpPWpGaD
Fosphenytoin—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	8.92e-05	0.00591	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—CYP24A1—multiple sclerosis	8.82e-05	0.00584	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—CYP27B1—multiple sclerosis	8.82e-05	0.00584	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metapathway biotransformation—CYP24A1—multiple sclerosis	8.7e-05	0.00576	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metapathway biotransformation—CYP27B1—multiple sclerosis	8.7e-05	0.00576	CbGpPWpGaD
Fosphenytoin—Asthenia—Methotrexate—multiple sclerosis	8.62e-05	0.000427	CcSEcCtD
Fosphenytoin—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	8.59e-05	0.00569	CbGpPWpGaD
Fosphenytoin—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	8.57e-05	0.00568	CbGpPWpGaD
Fosphenytoin—Nausea—Prednisone—multiple sclerosis	8.54e-05	0.000423	CcSEcCtD
Fosphenytoin—Pruritus—Methotrexate—multiple sclerosis	8.5e-05	0.000421	CcSEcCtD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	8.38e-05	0.00555	CbGpPWpGaD
Fosphenytoin—Diarrhoea—Methotrexate—multiple sclerosis	8.22e-05	0.000407	CcSEcCtD
Fosphenytoin—SCN5A—Axon guidance—PRNP—multiple sclerosis	8.05e-05	0.00533	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—IL10—multiple sclerosis	8e-05	0.0053	CbGpPWpGaD
Fosphenytoin—Dizziness—Methotrexate—multiple sclerosis	7.95e-05	0.000394	CcSEcCtD
Fosphenytoin—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	7.88e-05	0.00522	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	7.88e-05	0.00522	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.77e-05	0.00515	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.77e-05	0.00515	CbGpPWpGaD
Fosphenytoin—SCN5A—Cardiac Progenitor Differentiation—TGFB1—multiple sclerosis	7.74e-05	0.00513	CbGpPWpGaD
Fosphenytoin—Vomiting—Methotrexate—multiple sclerosis	7.64e-05	0.000378	CcSEcCtD
Fosphenytoin—Rash—Methotrexate—multiple sclerosis	7.58e-05	0.000375	CcSEcCtD
Fosphenytoin—Dermatitis—Methotrexate—multiple sclerosis	7.57e-05	0.000375	CcSEcCtD
Fosphenytoin—Headache—Methotrexate—multiple sclerosis	7.53e-05	0.000373	CcSEcCtD
Fosphenytoin—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	7.41e-05	0.00491	CbGpPWpGaD
Fosphenytoin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	7.23e-05	0.00479	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—CYP27B1—multiple sclerosis	7.18e-05	0.00476	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—CYP24A1—multiple sclerosis	7.18e-05	0.00476	CbGpPWpGaD
Fosphenytoin—Nausea—Methotrexate—multiple sclerosis	7.14e-05	0.000354	CcSEcCtD
Fosphenytoin—CYP2C9—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.08e-05	0.00469	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.08e-05	0.00469	CbGpPWpGaD
Fosphenytoin—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	6.78e-05	0.00449	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—PTPRC—multiple sclerosis	6.26e-05	0.00415	CbGpPWpGaD
Fosphenytoin—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	6.17e-05	0.00409	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	6.08e-05	0.00402	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	5.85e-05	0.00388	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IL4—multiple sclerosis	5.84e-05	0.00387	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—PRNP—multiple sclerosis	5.74e-05	0.00381	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	5.71e-05	0.00378	CbGpPWpGaD
Fosphenytoin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	5.67e-05	0.00375	CbGpPWpGaD
Fosphenytoin—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	5.44e-05	0.00361	CbGpPWpGaD
Fosphenytoin—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.14e-05	0.0034	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	5.11e-05	0.00338	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MERTK—multiple sclerosis	4.88e-05	0.00323	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SELPLG—multiple sclerosis	4.88e-05	0.00323	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—CD58—multiple sclerosis	4.88e-05	0.00323	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	4.74e-05	0.00314	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	4.74e-05	0.00314	CbGpPWpGaD
Fosphenytoin—SCN5A—L1CAM interactions—MAPK1—multiple sclerosis	4.72e-05	0.00313	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	4.67e-05	0.00309	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	4.67e-05	0.00309	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—ICAM1—multiple sclerosis	4.64e-05	0.00308	CbGpPWpGaD
Fosphenytoin—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.61e-05	0.00305	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—PTPRC—multiple sclerosis	4.47e-05	0.00296	CbGpPWpGaD
Fosphenytoin—CYP2B6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	4.41e-05	0.00292	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	4.34e-05	0.00288	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.2e-05	0.00278	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—CCL2—multiple sclerosis	4.15e-05	0.00275	CbGpPWpGaD
Fosphenytoin—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.11e-05	0.00273	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	3.87e-05	0.00257	CbGpPWpGaD
Fosphenytoin—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	3.75e-05	0.00248	CbGpPWpGaD
Fosphenytoin—CYP2C8—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.74e-05	0.00248	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	3.69e-05	0.00244	CbGpPWpGaD
Fosphenytoin—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.59e-05	0.00238	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IFNG—multiple sclerosis	3.53e-05	0.00234	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.45e-05	0.00228	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.39e-05	0.00224	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.39e-05	0.00224	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.37e-05	0.00223	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.37e-05	0.00223	CbGpPWpGaD
Fosphenytoin—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.34e-05	0.00221	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	3.3e-05	0.00219	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IL1B—multiple sclerosis	3.15e-05	0.00209	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IL2—multiple sclerosis	3.14e-05	0.00208	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.05e-05	0.00202	CbGpPWpGaD
Fosphenytoin—CYP2C9—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.04e-05	0.00201	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.02e-05	0.002	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.02e-05	0.002	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—PLEK—multiple sclerosis	3.02e-05	0.002	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	2.81e-05	0.00186	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.81e-05	0.00186	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—TYK2—multiple sclerosis	2.8e-05	0.00186	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	2.76e-05	0.00183	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	2.76e-05	0.00183	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.61e-05	0.00173	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—SRM—multiple sclerosis	2.53e-05	0.00168	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.5e-05	0.00166	CbGpPWpGaD
Fosphenytoin—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	2.47e-05	0.00164	CbGpPWpGaD
Fosphenytoin—SCN5A—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.46e-05	0.00163	CbGpPWpGaD
Fosphenytoin—CYP2B6—Biological oxidations—POMC—multiple sclerosis	2.34e-05	0.00155	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—TNF—multiple sclerosis	2.29e-05	0.00151	CbGpPWpGaD
Fosphenytoin—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	2.27e-05	0.0015	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—MMP9—multiple sclerosis	2.21e-05	0.00146	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—SRM—multiple sclerosis	2.14e-05	0.00142	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—SRM—multiple sclerosis	2.13e-05	0.00141	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—SELE—multiple sclerosis	2.13e-05	0.00141	CbGpPWpGaD
Fosphenytoin—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.1e-05	0.00139	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.06e-05	0.00137	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.04e-05	0.00135	CbGpPWpGaD
Fosphenytoin—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	2.01e-05	0.00133	CbGpPWpGaD
Fosphenytoin—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	2e-05	0.00132	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TYK2—multiple sclerosis	2e-05	0.00132	CbGpPWpGaD
Fosphenytoin—CYP2C8—Biological oxidations—POMC—multiple sclerosis	1.98e-05	0.00131	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—SRM—multiple sclerosis	1.91e-05	0.00127	CbGpPWpGaD
Fosphenytoin—ALB—Folate Metabolism—IL6—multiple sclerosis	1.85e-05	0.00122	CbGpPWpGaD
Fosphenytoin—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.82e-05	0.00121	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	1.82e-05	0.0012	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—MAPK1—multiple sclerosis	1.78e-05	0.00118	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP27B1—multiple sclerosis	1.78e-05	0.00118	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—CYP24A1—multiple sclerosis	1.78e-05	0.00118	CbGpPWpGaD
Fosphenytoin—CYP2C19—Biological oxidations—POMC—multiple sclerosis	1.77e-05	0.00117	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—SRM—multiple sclerosis	1.74e-05	0.00115	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—GPC5—multiple sclerosis	1.63e-05	0.00108	CbGpPWpGaD
Fosphenytoin—CYP2C9—Biological oxidations—POMC—multiple sclerosis	1.62e-05	0.00107	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—MMP9—multiple sclerosis	1.57e-05	0.00104	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—ITGA4—multiple sclerosis	1.54e-05	0.00102	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IFNB1—multiple sclerosis	1.53e-05	0.00101	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP24A1—multiple sclerosis	1.51e-05	0.001	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—CYP27B1—multiple sclerosis	1.51e-05	0.001	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP24A1—multiple sclerosis	1.5e-05	0.000994	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—CYP27B1—multiple sclerosis	1.5e-05	0.000994	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.47e-05	0.000977	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.47e-05	0.000971	CbGpPWpGaD
Fosphenytoin—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.47e-05	0.000971	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—STAT3—multiple sclerosis	1.4e-05	0.000927	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—GPC5—multiple sclerosis	1.38e-05	0.000914	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—GPC5—multiple sclerosis	1.37e-05	0.000909	CbGpPWpGaD
Fosphenytoin—SCN5A—Axon guidance—IL6—multiple sclerosis	1.37e-05	0.000908	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—RRM1—multiple sclerosis	1.35e-05	0.000895	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	1.35e-05	0.000892	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	1.35e-05	0.000892	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.32e-05	0.000872	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TGFB1—multiple sclerosis	1.3e-05	0.000859	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—MAPK1—multiple sclerosis	1.27e-05	0.000843	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—GPC5—multiple sclerosis	1.23e-05	0.000816	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP27B1—multiple sclerosis	1.23e-05	0.000813	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—CYP24A1—multiple sclerosis	1.23e-05	0.000813	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—TNF—multiple sclerosis	1.21e-05	0.000802	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.2e-05	0.000795	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.19e-05	0.000791	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—SRM—multiple sclerosis	1.15e-05	0.000761	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—RRM1—multiple sclerosis	1.14e-05	0.000758	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—RRM1—multiple sclerosis	1.14e-05	0.000753	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—GPC5—multiple sclerosis	1.12e-05	0.000744	CbGpPWpGaD
Fosphenytoin—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.07e-05	0.000706	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2RA—multiple sclerosis	1.05e-05	0.000695	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—RRM1—multiple sclerosis	1.02e-05	0.000676	CbGpPWpGaD
Fosphenytoin—SCN5A—Developmental Biology—IL6—multiple sclerosis	9.78e-06	0.000648	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	9.31e-06	0.000617	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—RRM1—multiple sclerosis	9.31e-06	0.000617	CbGpPWpGaD
Fosphenytoin—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	9.13e-06	0.000605	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.87e-06	0.000588	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.82e-06	0.000584	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	8.1e-06	0.000537	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	8.1e-06	0.000537	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.92e-06	0.000525	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—BCHE—multiple sclerosis	7.76e-06	0.000514	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.62e-06	0.000505	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.58e-06	0.000502	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—GPC5—multiple sclerosis	7.41e-06	0.000491	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	7.22e-06	0.000478	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.95e-06	0.00046	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.8e-06	0.000451	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—BCHE—multiple sclerosis	6.57e-06	0.000435	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—BCHE—multiple sclerosis	6.53e-06	0.000433	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	6.2e-06	0.000411	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	6.2e-06	0.000411	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—IL2—multiple sclerosis	6.15e-06	0.000408	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—RRM1—multiple sclerosis	6.14e-06	0.000407	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—BCHE—multiple sclerosis	5.86e-06	0.000388	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	5.66e-06	0.000375	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—BCHE—multiple sclerosis	5.35e-06	0.000354	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—TGFB1—multiple sclerosis	4.8e-06	0.000318	CbGpPWpGaD
Fosphenytoin—ALB—Hemostasis—MAPK1—multiple sclerosis	4.71e-06	0.000312	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—APOE—multiple sclerosis	4.67e-06	0.000309	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—POMC—multiple sclerosis	4.01e-06	0.000266	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—APOE—multiple sclerosis	3.95e-06	0.000262	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—APOE—multiple sclerosis	3.93e-06	0.00026	CbGpPWpGaD
Fosphenytoin—CYP2B6—Metabolism—ALB—multiple sclerosis	3.66e-06	0.000242	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—APOE—multiple sclerosis	3.53e-06	0.000234	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—BCHE—multiple sclerosis	3.53e-06	0.000234	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—POMC—multiple sclerosis	3.39e-06	0.000225	CbGpPWpGaD
Fosphenytoin—ALB—Metabolism—POMC—multiple sclerosis	3.38e-06	0.000224	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—APOE—multiple sclerosis	3.22e-06	0.000213	CbGpPWpGaD
Fosphenytoin—CYP2C8—Metabolism—ALB—multiple sclerosis	3.09e-06	0.000205	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—POMC—multiple sclerosis	3.03e-06	0.000201	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—POMC—multiple sclerosis	2.76e-06	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C19—Metabolism—ALB—multiple sclerosis	2.76e-06	0.000183	CbGpPWpGaD
Fosphenytoin—CYP2C9—Metabolism—ALB—multiple sclerosis	2.52e-06	0.000167	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—APOE—multiple sclerosis	2.12e-06	0.00014	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—POMC—multiple sclerosis	1.82e-06	0.000121	CbGpPWpGaD
Fosphenytoin—CYP3A4—Metabolism—ALB—multiple sclerosis	1.66e-06	0.00011	CbGpPWpGaD
